Yale Jen
Stock Analyst at Laidlaw & Co.
(0.05)
# 4,134
Out of 4,786 analysts
15
Total ratings
14.29%
Success rate
-46.03%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $71.99 | +45.85% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $10.46 | +81.64% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $10 | $1.79 | +458.66% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $6.43 | +646.50% | 1 | Jul 29, 2024 | |
| MEIP MEI Pharma | Downgrades: Hold | n/a | $2.35 | - | 1 | Jul 23, 2024 | |
| AFMD Affimed | Maintains: Buy | $15 → $25 | $0.78 | +3,100.61% | 1 | Jun 13, 2024 | |
| PHGE BiomX | Initiates: Buy | $25 | $0.57 | +4,293.67% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $7.5 | $0.20 | +3,724.58% | 1 | Mar 18, 2024 | |
| CING Cingulate | Downgrades: Hold | n/a | $4.35 | - | 2 | Dec 22, 2023 | |
| SILO Silo Pharma | Initiates: Buy | $10 | $1.25 | +700.00% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.46 | - | 1 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $1.30 | +18,361.54% | 1 | Sep 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $600 | $0.54 | +111,196.61% | 1 | Sep 13, 2021 |
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $71.99
Upside: +45.85%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $10.46
Upside: +81.64%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $10
Current: $1.79
Upside: +458.66%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $6.43
Upside: +646.50%
MEI Pharma
Jul 23, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.35
Upside: -
Affimed
Jun 13, 2024
Maintains: Buy
Price Target: $15 → $25
Current: $0.78
Upside: +3,100.61%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $25
Current: $0.57
Upside: +4,293.67%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $7.5
Current: $0.20
Upside: +3,724.58%
Cingulate
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.35
Upside: -
Silo Pharma
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $1.25
Upside: +700.00%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.46
Upside: -
Sep 6, 2022
Initiates: Buy
Price Target: $240
Current: $1.30
Upside: +18,361.54%
Sep 13, 2021
Initiates: Buy
Price Target: $600
Current: $0.54
Upside: +111,196.61%